TSCAN THERAPEUTICS INC. - COMMON STOCK

TScan Therapeutics to Participate in the Cowen 43rd Annual Health Care Conference

01 мар 2023 07:00:01 Источник Nasdaq GlobeNewswire

TScan Therapeutics Announces Presentation at the H.C. Wainwright Cell Therapy Virtual Conference

21 фев 2023 07:00:01 Источник Nasdaq GlobeNewswire

TScan Therapeutics Announces FDA Clearance of Three Investigational New Drug Applications for the Treatment of Solid Tumors

23 янв 2023 07:00:00 Источник Nasdaq GlobeNewswire

TScan Therapeutics Announces 2023 Clinical Plans and Highlights Recent Progress

05 янв 2023 07:00:00 Источник Nasdaq GlobeNewswire

TScan Therapeutics Presents Phase 1 Umbrella Trial in Progress on HA-1 (TSC-100) and HA-2 (TSC-101) at the 64th American Society of Hematology Annual Meeting 2022

12 дек 2022 07:00:00 Источник Nasdaq GlobeNewswire

TScan Therapeutics Named the Highest-Placed Midsize Biotechnology Company in The Top Places to Work for 2022 by The Boston Globe

01 дек 2022 08:00:00 Источник Nasdaq GlobeNewswire

TScan Therapeutics to Participate in the 5th Annual Evercore ISI HealthCONx Conference

22 ноя 2022 07:00:00 Источник Nasdaq GlobeNewswire

TScan Therapeutics Presents Preclinical Data for Solid Tumor Program at the 37th Society for Immunotherapy of Cancer Annual Meeting

11 ноя 2022 07:00:00 Источник Nasdaq GlobeNewswire

TScan Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update

09 ноя 2022 07:00:01 Источник Nasdaq GlobeNewswire

TScan Therapeutics Announces Upcoming Virtual Investor Event

07 ноя 2022 07:00:01 Источник Nasdaq GlobeNewswire

TScan Therapeutics Announces Upcoming Poster Presentation at the 64th American Society of Hematology Annual Meeting and Exposition

03 ноя 2022 09:34:04 Источник Nasdaq GlobeNewswire

TScan Therapeutics Announces Upcoming Poster Presentations at the 37th Society for Immunotherapy of Cancer Annual Meeting

05 окт 2022 08:33:23 Источник Nasdaq GlobeNewswire

TScan Therapeutics to Participate in Upcoming Investor Conferences

22 сен 2022 07:00:00 Источник Nasdaq GlobeNewswire

TScan Therapeutics Secures Convertible Debt Facility for up to $60 Million with K2 HealthVentures

12 сен 2022 07:00:01 Источник Nasdaq GlobeNewswire

TScan Therapeutics to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference

07 сен 2022 07:00:01 Источник Nasdaq GlobeNewswire

TScan Therapeutics Reports Second Quarter 2022 Financial Results and Highlights Recent Progress

10 авг 2022 07:00:00 Источник Nasdaq GlobeNewswire

TScan Therapeutics to Participate in the 13th Annual Wedbush PacGrow Healthcare Conference

03 авг 2022 07:00:02 Источник Nasdaq GlobeNewswire

TScan Therapeutics Announces Publication in Cell Highlighting the Discovery of Tumor Antigens and TCRs for the Treatment of Solid Tumors Using Foundational Screening Technology

11 июл 2022 07:00:00 Источник Nasdaq GlobeNewswire

TScan Therapeutics Appoints Debora Barton, M.D., as Chief Medical Officer

07 июл 2022 07:00:00 Источник Nasdaq GlobeNewswire

TScan Therapeutics to Participate in the LifeSci 2nd Annual Genetic Medicines Symposium

22 июн 2022 07:00:01 Источник Nasdaq GlobeNewswire